Specialty Pharmacy

A synthetic particle awakens dormant HIV cells then knocks them out.

The grant from the National Multiple Sclerosis Society aims to support the development of a potential oral treatment for progressive forms of MS.

An oncoprotein produced by the human papillomavirus results in cells that proliferate and do not die.

Moses Zoanna, CEO of Compliance Meds Technologies, discusses the impact of mobile health.

A biochip may be able to detect HIV in a drop of blood and display the results within 10 seconds.

Top news of the day from across the healthcare landscape.

Cancer patient Beth Wallace provides advice to patients with leiomyosarcoma, as well as to women with cancer in general.

Mastectomy rates increased after actress Angelia Jolie announced her procedure.

Top news from across the healthcare landscape.

Top news of the week from Specialty Pharmacy Times.

Spending for adalimumab has tripled from 2012 from $4.5 billion.

Pharmacists who are unfamiliar with either the principles of infectious disease or HIV may miss errors.

Mass spectrometry device rapidly identifies molecular profile of cancerous tissue.

Beth Wallace was always one to advocate for herself in different areas of her life, but when it came to her health, she left it to the doctors. Here, she discusses the importance of education and being your own advocate.

A look into the differences between specialty pharmacies in integrated delivery networks and academic medical centers.

Payers and manufacturers look for specialty pharmacy partners with several key aspects.

Consistency among caregivers can be an important factor for patients undergoing treatment for cancer.

Several drugs are in the pipeline for the treatment of specialty conditions, including cancer and multiple sclerosis.

The investigational regimen may be appropriate for a broad range of HIV-positive patients.

Reducing the cost of antiretroviral therapy could produce even more savings in the treatment of HIV.

Top news of the day from across the health care landscape.

Two different Copaxone injection doses approved for relapsing forms of multiple sclerosis.

Patients with chronic kidney disease are at risk for several comorbid conditions, including cardiovascular disease.

Cancer patient Beth Wallace speaks about her support system and the impact they have made on her life.

The fate of the 340B program is unclear amid several proposals to make changes.

The pharma giant will now focus on its PD-1 cancer immunotherapy Keytruda.

Ramping up programs for injection drug users is a key part in preventing transmission of hepatitis C.

Top news of the day from across the health care landscape.